Australia’s practitioner only
nutritional and therapeutic
supplements company BioCeuticals,
has announced a research
partnership with the National
Institute of Complementary Medicine
(NICM) at Western Sydney
University, where there is a focus
on complementary medicine
research and policy.
The three-year long pilot trial
will explore the clinical effect of
herbal and nutritional supplements
on cognitive function in elderly
patients living with Mild Cognitive
Impairment (MCI).
The university is seeking a
doctoral candidate to undertake
the research seeking to assess the
impact of early intervention in MCI.
Some products for evaluation will
include brahmi, ginkgo, ginseng and
alpha-lipoic acid.The above article was sent to subscribers in Pharmacy Daily's issue from 21 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Dec 15
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.